1.

Record Nr.

UNINA9910817644803321

Autore

Wailoo Keith

Titolo

The troubled dream of genetic medicine : ethnicity and innovation in Tay-Sachs, cystic fibrosis, and sickle cell disease / / Keith Wailoo and Stephen Pemberton

Pubbl/distr/stampa

Baltimore, : Johns Hopkins University Press, 2006

ISBN

0-8018-8936-7

Edizione

[1st ed.]

Descrizione fisica

1 online resource (viii, 249 pages)

Altri autori (Persone)

PembertonStephen Gregory

Disciplina

616/.042

Soggetti

Genetic disorders - Research - Moral and ethical aspects

Ethnic groups - Diseases

Tay-Sachs disease - Genetic aspects

Cystic fibrosis - Genetic aspects

Sickle cell anemia - Genetic aspects

Lingua di pubblicazione

Inglese

Formato

Materiale a stampa

Livello bibliografico

Monografia

Note generali

Bibliographic Level Mode of Issuance: Monograph

Nota di bibliografia

Includes bibliographical references (p. [175]-222) and index.

Nota di contenuto

Ethnic symbols in conflicted times Eradicating a "Jewish gene": promises and pitfalls in the fight against Tay-Sachs disease Risky business in white America: gene therapy and other ventures in the treatment of cystic fibrosis A perilous lottery for the Black family: sickle cells, social justice, and the new therapeutic gamble Dreams amid diversity

Sommario/riassunto

Why do racial and ethnic controversies become attached, as they often do, to discussions of modern genetics? How do theories about genetic difference become entangled with political debates about cultural and group differences in America? Such issues are a conspicuous part of the histories of three hereditary diseases: Tay-Sachs, commonly identified with Jewish Americans; cystic fibrosis, often labeled a "Caucasian" disease; and sickle cell disease, widely associated with African Americans. In this captivating account, historians Keith Wailoo and Stephen Pemberton reveal how these diseases - fraught with ethnic and racial meanings for many Americans - became objects of biological fascination and crucibles of social debate. Peering behind the headlines of breakthrough treatments and coming cures, they tell a complex



story: about different kinds of suffering and faith, about unequal access to the promises and perils of modern medicine, and about how Americans consume innovation and how they come to believe in, or resist, the notion of imminent medical breakthroughs. With Tay-Sachs, cystic fibrosis, and sickle cell disease as a powerful backdrop, the authors provide a glimpse into a diverse America where racial ideologies, cultural politics, and conflicting beliefs about the power of genetics shape disparate health care expectations and experiences.